Overview
Illumina, Inc., based in the United States, operates predominantly within the biotechnology industry, specializing in the development, manufacture, and marketing of integrated systems for the analysis of genetic variation and biological function. The company is a leading entity in the genomic sequencing space, providing technologies that serve as catalysts for discoveries in genomics research. Among its key projects and initiatives, Illumina focuses on advancing precision medicine by creating tools and systems that enable large-scale analysis of genetic material. These technological advancements facilitate a plethora of applications, including cancer diagnostics, complex disease understanding, and agricultural biology. Through strategic partnerships and continual innovation, Illumina strives to enhance the capabilities of genomic sequencing and expand its application in science and healthcare.
Basic Stats
The share price of Illumina, Inc. as of September 5, 2025 is $98.93 / share. This is a decrease of -1.03% from the prior week. The market cap (or net worth) of Illumina, Inc. as of September 5, 2025 is $15,511.60 MM.
The Factor Analysis chart (below right) shows a view of Illumina, Inc. from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | 15,511.60 MM |
| EV | 16,568.60 MM |
| Shares Out. | 157.00 MM |
| Earnings Date | |
| EPS (TTM) | 8.01 |
| Dividend Yield | |
| Ex-Dividend Date | |
| Borrow Rate | 0.33 |
| Short Shares Avail. | 2.30 MM |
| Short Interest | 7.52 MM |
| Short Float | 5.03 % |
| Days to Cover | 7.62 days |
| Risk Free Rate | 4.17 % |
| Price Change (1 yr) | -23.86 % |
| Volatility (1 yr) | 0.42 |
| Beta | 0.90 |
| Sharpe Ratio (1 yr) | -0.67 |
| Sortino Ratio (1 yr) | -1.08 |
| PE Ratio | 12.34 |
| Price/Book | 6.87 |
| Price/TBV | 17.10 |
| Book/Market | 0.15 |
| EBIT/EV | 0.08 |
| EBIT(3yr avg)/EV | -0.11 |
| ROA | 0.21 |
| ROE | 0.88 |
| ROIC | 0.26 |
| CROIC | 0.00 |
| OCROIC | 0.24 |
| Implied Volatility | 39.16 % |
| Put/Call OI Ratio | 0.21 |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target
The average one-year price target for Illumina, Inc. is $114.55. The forecasts range from a low of $75.75 to a high of $194.25. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Illumina, Inc.. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2023-01-17 | Canaccord Genuity | Buy | Maintains | |
| 2023-01-25 | Argus Research | Buy | Hold | Downgrade |
| 2022-12-20 | OTR Global | Mixed | Positive | Upgrade |
| 2022-12-12 | Citigroup | Neutral | Sell | Downgrade |
| 2022-12-07 | RBC Capital | Outperform | Initiate | |
| 2022-11-14 | Piper Sandler | Overweight | Maintains | |
| 2022-11-07 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-11-04 | Credit Suisse | Neutral | Maintains | |
| 2022-10-04 | SVB Leerink | Market Perform | Outperform | Upgrade |
| 2022-09-30 | Barclays | Underweight | Maintains | |
| 2022-09-28 | Evercore ISI Group | In-Line | Outperform | Upgrade |
| 2022-08-25 | Credit Suisse | Neutral | Initiate | |
| 2022-08-17 | UBS | Neutral | Maintains | |
| 2022-08-15 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-08-12 | SVB Leerink | Market Perform | Maintains | |
| 2022-08-12 | Stifel | Buy | Maintains | |
| 2022-08-12 | Piper Sandler | Overweight | Maintains | |
| 2022-08-12 | Citigroup | Neutral | Maintains | |
| 2022-07-14 | Barclays | Equal-Weight | Underweight | Downgrade |
| 2022-07-13 | Barclays | Equal-Weight | Underweight | Downgrade |
| 2022-07-08 | Citigroup | Neutral | Maintains | |
| 2022-05-16 | Piper Sandler | Overweight | Maintains | |
| 2022-05-09 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-05-06 | Citigroup | Neutral | Maintains | |
| 2022-03-29 | OTR Global | Mixed | Positive | Upgrade |
| 2022-02-15 | Piper Sandler | Overweight | Maintains | |
| 2022-02-11 | SVB Leerink | Market Perform | Maintains | |
| 2022-01-18 | Stifel | Hold | Buy | Upgrade |
| 2022-01-12 | Barclays | Underweight | Equal-Weight | Upgrade |
| 2022-01-11 | SVB Leerink | Market Perform | Maintains | |
| 2022-01-11 | Barclays | Underweight | Equal-Weight | Upgrade |
| 2022-01-10 | Barclays | Underweight | Maintains | |
| 2022-01-07 | B of A Securities | Underperform | Neutral | Upgrade |
| 2021-10-19 | SVB Leerink | Market Perform | Maintains | |
| 2021-10-01 | OTR Global | Positive | Mixed | Downgrade |
| 2021-08-19 | SVB Leerink | Outperform | Market Perform | Downgrade |
| 2021-08-06 | Barclays | Underweight | Maintains | |
| 2021-07-13 | Barclays | Underweight | Maintains | |
| 2021-06-01 | Evercore ISI Group | Underperform | In-Line | Upgrade |
| 2021-04-28 | Wells Fargo | Underweight | Maintains | |
| 2021-04-28 | Canaccord Genuity | Buy | Maintains | |
| 2021-04-06 | Wells Fargo | Underweight | Maintains | |
| 2021-04-06 | Canaccord Genuity | Buy | Maintains | |
| 2021-03-31 | Canaccord Genuity | Hold | Buy | Upgrade |
| 2021-03-31 | Atlantic Equities | Overweight | Neutral | Downgrade |
| 2021-03-03 | Barclays | Underweight | Initiate | |
| 2021-02-16 | BTIG | Buy | Maintains | |
| 2021-02-12 | SVB Leerink | Outperform | Maintains | |
| 2021-02-12 | Canaccord Genuity | Hold | Maintains | |
| 2020-12-22 | Piper Sandler | Neutral | Overweight | Upgrade |
| 2020-12-17 | BTIG | Neutral | Buy | Upgrade |
| 2020-12-07 | SVB Leerink | Outperform | Maintains | |
| 2020-10-30 | SVB Leerink | Outperform | Maintains | |
| 2020-10-13 | Guggenheim | Buy | Neutral | Downgrade |
| 2020-09-30 | Atlantic Equities | Overweight | Initiate | |
| 2020-09-22 | UBS | Buy | Neutral | Downgrade |
| 2020-09-22 | SVB Leerink | Outperform | Maintains | |
| 2020-09-22 | Stifel | Buy | Hold | Downgrade |
| 2020-09-22 | Canaccord Genuity | Hold | Maintains | |
| 2020-09-22 | Baird | Neutral | Maintains | |
| 2020-09-21 | Guggenheim | Neutral | Buy | Upgrade |
| 2020-09-09 | Morgan Stanley | Equal-Weight | Initiate | |
| 2020-08-07 | SVB Leerink | Outperform | Maintains | |
| 2020-08-07 | Piper Sandler | Overweight | Neutral | Downgrade |
| 2020-07-07 | Guggenheim | Buy | Neutral | Downgrade |
| 2020-05-01 | Wells Fargo | Underweight | Maintains | |
| 2020-05-01 | Stifel | Buy | Maintains | |
| 2020-04-24 | Citigroup | Buy | Neutral | Downgrade |
| 2020-04-21 | Baird | Outperform | Neutral | Downgrade |
| 2020-04-15 | Baird | Outperform | Maintains | |
| 2020-04-02 | Stifel | Buy | Maintains | |
| 2020-03-30 | Wells Fargo | Underweight | Maintains | |
| 2020-03-26 | Barclays | Overweight | Maintains | |
| 2020-03-20 | Citigroup | Buy | Maintains | |
| 2020-01-30 | Wells Fargo | Underweight | Maintains | |
| 2020-01-30 | Citigroup | Buy | Maintains | |
| 2020-01-09 | Piper Sandler | Overweight | Maintains | |
| 2020-01-08 | Wells Fargo | Underweight | Initiate | |
| 2020-01-07 | Citigroup | Buy | Initiate | |
| 2020-01-02 | Evercore ISI Group | Outperform | In-Line | Downgrade |
| 2019-12-18 | Cowen & Co. | Outperform | Maintains | |
| 2019-11-15 | Stifel Nicolaus | Buy | Initiate | |
| 2019-10-25 | Piper Jaffray | Overweight | Maintains | |
| 2019-10-25 | Guggenheim | Buy | Initiate | |
| 2019-10-25 | Canaccord Genuity | Hold | Maintains | |
| 2019-09-25 | Argus Research | Buy | Maintains | |
| 2019-07-30 | UBS | Buy | Maintains | |
| 2019-07-30 | Piper Jaffray | Overweight | Maintains | |
| 2019-07-30 | Canaccord Genuity | Buy | Hold | Downgrade |
| 2019-07-12 | Deutsche Bank | Hold | Maintains | |
| 2019-07-12 | Bank of America | Buy | Underperform | Downgrade |
| 2019-01-25 | Deutsche Bank | Buy | Hold | Downgrade |
| 2019-01-07 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2019-01-03 | UBS | Neutral | Buy | Upgrade |
| 2018-10-24 | Barclays | Overweight | Overweight | Maintains |
| 2018-08-10 | Argus | Buy | Buy | Maintains |
| 2018-08-07 | Morgan Stanley | Underweight | Equal-Weight | Upgrade |
| 2018-07-31 | Deutsche Bank | Buy | Buy | Maintains |
| 2018-07-31 | Citigroup | Buy | Buy | Maintains |
| 2018-07-31 | Canaccord Genuity | Buy | Buy | Maintains |
| 2018-07-31 | Barclays | Overweight | Overweight | Maintains |
| 2018-07-31 | Bank of America | Buy | Buy | Maintains |
| 2018-07-17 | PiperJaffray | Overweight | Overweight | Maintains |
| 2018-07-13 | Morgan Stanley | Underweight | Underweight | Maintains |
| 2018-07-10 | Cowen & Co. | Outperform | Outperform | Maintains |
| 2018-06-25 | Citigroup | Buy | Buy | Maintains |
| 2018-05-31 | Morgan Stanley | Underweight | Underweight | Maintains |
| 2018-05-29 | Canaccord Genuity | Buy | Buy | Maintains |
| 2018-05-07 | Barclays | Equal-Weight | Overweight | Upgrade |
| 2018-04-25 | Morgan Stanley | Underweight | Underweight | Maintains |
| 2018-04-25 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2018-04-25 | Baird | Outperform | Outperform | Maintains |
| 2018-04-11 | Morgan Stanley | Underweight | Underweight | Maintains |
| 2018-02-06 | Citigroup | Neutral | Buy | Maintains |
| 2018-01-31 | Morgan Stanley | Underweight | Underweight | Maintains |
| 2018-01-31 | Leerink Swann | Outperform | Outperform | Maintains |
| 2018-01-31 | First Analysis | Equal-Weight | Overweight | Upgrade |
| 2018-01-31 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2018-01-05 | William Blair | Outperform | Market Perform | Downgrade |
| 2018-01-05 | BTIG Research | Neutral | Initiate | |
| 2018-01-04 | Evercore ISI Group | Outperform | Initiate | |
| 2018-01-02 | Wells Fargo | Market Perform | Outperform | Upgrade |
| 2017-12-14 | Morgan Stanley | Underweight | Maintains | |
| 2017-10-25 | Wells Fargo | Market Perform | Maintains | |
| 2017-10-25 | Citigroup | Neutral | Maintains | |
| 2017-10-25 | Barclays | Equal-Weight | Maintains | |
| 2017-10-25 | Bank of America | Buy | Maintains | |
| 2017-10-25 | Baird | Neutral | Outperform | Upgrade |
| 2017-10-23 | Janney Capital | Sell | Neutral | Upgrade |
| 2017-10-23 | Deutsche Bank | Hold | Buy | Upgrade |
| 2017-09-13 | Argus | Buy | Maintains | |
| 2017-08-07 | Canaccord Genuity | Hold | Buy | Upgrade |
| 2017-07-10 | Morgan Stanley | Underweight | Maintains | |
| 2017-03-20 | Leerink Swann | Market Perform | Outperform | Upgrade |
| 2017-02-27 | Evercore ISI Group | Hold | Buy | Upgrade |
| 2017-01-18 | Deutsche Bank | Hold | Initiate | |
| 2017-01-10 | Bank of America | Neutral | Buy | Upgrade |
| 2016-11-02 | First Analysis | Equal-Weight | Underweight | Downgrade |
| 2016-10-12 | Citigroup | Neutral | Maintains | |
| 2016-10-11 | Janney Capital | Neutral | Sell | Downgrade |
| 2016-10-11 | Citigroup | Buy | Neutral | Downgrade |
| 2016-10-11 | Barclays | Equal-Weight | Maintains | |
| 2016-09-12 | Citigroup | Buy | Maintains | |
| 2016-08-22 | CL King | Buy | Neutral | Downgrade |
| 2016-08-08 | Argus | Buy | Maintains | |
| 2016-07-27 | JP Morgan | Overweight | Maintains | |
| 2016-07-05 | Morgan Stanley | Underweight | Downgrade | |
| 2016-06-22 | CL King | Buy | Initiate | |
| 2016-05-04 | Citigroup | Buy | Maintains | |
| 2016-05-03 | Nomura | Buy | Maintains | |
| 2016-05-03 | Morgan Stanley | Equal-Weight | Maintains | |
| 2016-04-19 | Morgan Stanley | Equal-Weight | Maintains | |
| 2016-04-19 | Leerink Swann | Market Perform | Maintains | |
| 2016-04-19 | Cowen & Co. | Outperform | Maintains | |
| 2016-04-19 | Cantor Fitzgerald | Buy | Hold | Downgrade |
| 2016-04-19 | Barclays | Equal-Weight | Maintains | |
| 2016-04-19 | Bank of America | Buy | Neutral | Downgrade |
| 2016-03-30 | Argus | Buy | Initiate | |
| 2016-02-04 | Canaccord Genuity | Buy | Hold | Downgrade |
| 2016-02-03 | Baird | Neutral | Maintains | |
| 2016-01-11 | Deutsche Bank | Hold | Maintains | |
| 2016-01-07 | Wells Fargo | Outperform | Market Perform | Downgrade |
| 2016-01-06 | Deutsche Bank | Hold | Initiate | |
| 2016-01-06 | Avondale Partners | Market Perform | Initiate | |
| 2015-10-21 | PiperJaffray | Overweight | Maintains | |
| 2015-10-13 | Barclays | Equal-Weight | Maintains | |
| 2015-10-06 | Mizuho | Buy | Neutral | Downgrade |
| 2015-10-06 | Leerink Swann | Market Perform | Maintains | |
| 2015-10-02 | Cowen & Co. | Outperform | Maintains | |
| 2015-10-01 | Leerink Swann | Outperform | Market Perform | Downgrade |
| 2015-08-27 | Cantor Fitzgerald | Buy | Initiate | |
| 2015-07-22 | Janney Capital | Buy | Neutral | Downgrade |
| 2015-07-17 | Canaccord Genuity | Buy | Initiate | |
| 2015-05-21 | Morgan Stanley | Equal-Weight | Overweight | Upgrade |
| 2015-04-23 | Tigress Financial | Buy | Strong Buy | Upgrade |
| 2015-04-22 | Citigroup | Buy | Maintains | |
| 2015-03-10 | UBS | Buy | Initiate | |
| 2015-01-28 | Barclays | Equal-Weight | Maintains | |
| 2015-01-06 | JP Morgan | Overweight | Maintains | |
| 2014-10-27 | Stifel Nicolaus | Buy | Maintains | |
| 2014-10-21 | Janney Capital | Neutral | Buy | Upgrade |
| 2014-10-16 | PiperJaffray | Neutral | Overweight | Upgrade |
| 2014-10-03 | BTIG Research | Buy | Initiate | |
| 2014-09-08 | Morgan Stanley | Equal-weight | Initiate | |
| 2014-08-20 | Wedbush | Neutral | Outperform | Upgrade |
| 2014-08-12 | Stifel Nicolaus | Buy | Initiate | |
| 2014-08-01 | Tigress Financial | Buy | Initiate | |
| 2014-07-24 | Macquarie | Outperform | Maintains | |
| 2014-07-24 | JP Morgan | Overweight | Maintains | |
| 2014-07-24 | Credit Suisse | Outperform | Maintains | |
| 2014-04-23 | Maxim Group | Hold | Buy | Upgrade |
| 2014-04-23 | Leerink Swann | Outperform | Maintains | |
| 2014-04-23 | Bank of America | Buy | Maintains | |
| 2014-04-02 | Macquarie | Neutral | Outperform | Upgrade |
| 2014-03-05 | JMP Securities | Market Outperform | Maintains | |
| 2014-02-18 | Bank of America | Buy | Maintains | |
| 2013-12-19 | Mizuho | Buy | Maintains | |
| 2013-12-18 | JMP Securities | Market Outperform | Initiate | |
| 2013-12-12 | Bank of America | Buy | Maintains | |
| 2013-09-09 | Wells Fargo | Outperform | Initiate | |
| 2013-08-15 | Janney Capital | Neutral | Initiate | |
| 2013-07-24 | Credit Suisse | Outperform | Maintains | |
| 2013-07-02 | PiperJaffray | Overweight | Neutral | Downgrade |
| 2013-05-15 | Bank of America | Buy | Maintains | |
| 2013-04-23 | Credit Suisse | Outperform | Maintains | |
| 2013-03-01 | UBS | Neutral | Buy | Upgrade |
| 2013-01-29 | ISI Group | Neutral | Maintains | |
| 2013-01-29 | First Analysis | Overweight | Equal-Weight | Downgrade |
| 2013-01-29 | Credit Suisse | Outperform | Maintains | |
| 2013-01-29 | Cantor Fitzgerald | Hold | Maintains | |
| 2013-01-08 | ISI Group | Neutral | Maintains | |
| 2013-01-04 | Wedbush | Outperform | Neutral | Downgrade |
| 2013-01-04 | PiperJaffray | Neutral | Overweight | Upgrade |
| 2012-11-26 | Baird | Outperform | Neutral | Downgrade |
| 2012-10-24 | Goldman Sachs | Neutral | Maintains | |
| 2012-10-24 | CLSA | Outperform | Underperform | Downgrade |
| 2012-10-16 | Citigroup | Neutral | Maintains | |
| 2012-10-10 | Cantor Fitzgerald | Hold | Maintains | |
| 2012-07-23 | Barclays | Overweight | Maintains | |
| 2012-07-10 | ISI Group | Market Weight | Initiate | |
| 2012-04-24 | Wedbush | Outperform | Maintains | |
| 2012-04-24 | UBS | Neutral | Maintains | |
| 2012-04-24 | JP Morgan | Overweight | Maintains | |
| 2012-04-24 | Citigroup | Neutral | Maintains | |
| 2012-03-22 | Morgan Stanley | Equal-Weight | Initiate | |
| 2012-03-06 | Morgan Stanley | Equal-Weight | Initiate | |
| 2023-01-05 | Scotiabank | Sector Perform | Initiate | |
| 2023-02-08 | Piper Sandler | Overweight | Maintains | |
| 2023-02-08 | JP Morgan | Neutral | Maintains | |
| 2023-02-08 | RBC Capital | Outperform | Maintains | |
| 2023-02-08 | Barclays | Underweight | Maintains | |
| 2023-02-08 | SVB Leerink | Outperform | Maintains | |
| 2023-02-14 | UBS | Neutral | Maintains | |
| 2023-03-15 | RBC Capital | Outperform | Maintains | |
| 2023-04-26 | Stifel | Buy | Maintains | |
| 2023-04-26 | RBC Capital | Outperform | Maintains | |
| 2023-04-26 | Baird | Neutral | Maintains | |
| 2023-06-12 | Canaccord Genuity | Buy | Buy | Reiterate |
| 2023-08-16 | Canaccord Genuity | Buy | Buy | Maintains |
| 2024-01-04 | TD Cowen | Outperform | Market Perform | Downgrade |
| 2023-11-13 | Piper Sandler | Overweight | Overweight | Maintains |
| 2023-11-10 | Canaccord Genuity | Buy | Hold | Downgrade |
| 2023-09-01 | Evercore ISI Group | Outperform | Outperform | Reiterate |
| 2023-07-06 | Canaccord Genuity | Buy | Buy | Reiterate |
| 2023-08-14 | HSBC | Buy | Buy | Maintains |
| 2023-08-10 | Credit Suisse | Neutral | Neutral | Maintains |
| 2023-08-10 | Evercore ISI Group | Outperform | Outperform | Maintains |
| 2023-12-19 | Scotiabank | Sector Perform | Sector Outperform | Upgrade |
| 2023-12-18 | Scotiabank | Sector Perform | Sector Outperform | Upgrade |
| 2023-08-10 | Stifel | Buy | Buy | Maintains |
| 2023-08-10 | Citigroup | Sell | Sell | Maintains |
| 2023-08-10 | JP Morgan | Neutral | Neutral | Maintains |
| 2023-10-16 | Piper Sandler | Overweight | Overweight | Maintains |
| 2024-01-25 | Barclays | Underweight | Underweight | Maintains |
| 2023-09-28 | Bernstein | Underperform | Initiate | |
| 2023-12-13 | Wolfe Research | Outperform | Initiate | |
| 2023-10-12 | Stifel | Buy | Buy | Reiterate |
| 2023-08-15 | Piper Sandler | Overweight | Overweight | Maintains |
| 2023-12-11 | Citigroup | Sell | Neutral | Upgrade |
| 2023-12-19 | RBC Capital | Outperform | Outperform | Maintains |
| 2023-12-14 | Guggenheim | Buy | Initiate | |
| 2023-12-14 | Stephens & Co. | Overweight | Initiate | |
| 2023-09-29 | Barclays | Underweight | Underweight | Maintains |
| 2023-09-29 | Stifel | Buy | Buy | Maintains |
| 2024-02-09 | RBC Capital | Outperform | Outperform | Reiterate |
| 2023-12-12 | B of A Securities | Neutral | Underperform | Downgrade |
| 2024-05-07 | Stephens & Co. | Overweight | Overweight | Reiterate |
| 2024-05-03 | Baird | Neutral | Neutral | Maintains |
| 2024-02-14 | Stephens & Co. | Overweight | Overweight | Reiterate |
| 2024-05-06 | Scotiabank | Sector Outperform | Sector Outperform | Maintains |
| 2024-03-20 | OTR Global | Positive | Mixed | Downgrade |
| 2024-04-10 | Barclays | Underweight | Underweight | Maintains |
| 2024-04-10 | Stephens & Co. | Overweight | Overweight | Reiterate |
| 2024-04-09 | RBC Capital | Outperform | Outperform | Reiterate |
| 2024-06-06 | TD Cowen | Hold | Hold | Maintains |
| 2024-06-11 | Evercore ISI Group | Outperform | Outperform | Maintains |
| 2024-07-10 | Stephens & Co. | Overweight | Overweight | Reiterate |
| 2024-07-10 | Citigroup | Neutral | Buy | Upgrade |
| 2024-07-01 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-11-05 | Citigroup | Buy | Buy | Maintains |
| 2024-11-05 | JP Morgan | Neutral | Neutral | Maintains |
| 2024-11-05 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-11-05 | UBS | Neutral | Neutral | Maintains |
| 2024-11-05 | TD Cowen | Buy | Buy | Maintains |
| 2024-11-05 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2024-11-05 | Canaccord Genuity | Hold | Hold | Maintains |
| 2024-11-12 | Morgan Stanley | Equal-Weight | Reiterate | |
| 2024-11-12 | Stephens & Co. | Overweight | Overweight | Maintains |
| 2025-07-09 | Citigroup | Neutral | Sell | Downgrade |
| 2025-05-09 | Guggenheim | Buy | Buy | Maintains |
| 2024-08-14 | RBC Capital | Outperform | Outperform | Reiterate |
| 2024-08-14 | TD Cowen | Hold | Buy | Upgrade |
| 2024-08-14 | Barclays | Underweight | Equal-Weight | Upgrade |
| 2025-06-24 | Barclays | Underweight | Underweight | Maintains |
| 2024-10-17 | HSBC | Hold | Buy | Upgrade |
| 2025-08-01 | Canaccord Genuity | Hold | Hold | Maintains |
| 2025-08-01 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-08-28 | Argus Research | Hold | Buy | Upgrade |
| 2025-03-05 | Baird | Neutral | Neutral | Maintains |
| 2024-08-16 | Daiwa Capital | Neutral | Buy | Upgrade |
| 2024-08-15 | Scotiabank | Sector Outperform | Sector Outperform | Maintains |
| 2025-02-07 | RBC Capital | Outperform | Outperform | Maintains |
| 2025-02-07 | Guggenheim | Buy | Buy | Maintains |
| 2025-02-07 | Canaccord Genuity | Hold | Hold | Maintains |
| 2025-04-07 | Citigroup | Neutral | Neutral | Maintains |
| 2024-11-06 | Baird | Neutral | Neutral | Maintains |
| 2025-02-11 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2024-08-07 | UBS | Neutral | Neutral | Maintains |
| 2024-08-07 | TD Cowen | Hold | Hold | Maintains |
| 2024-08-07 | Baird | Neutral | Neutral | Maintains |
| 2024-08-07 | RBC Capital | Outperform | Outperform | Reiterate |
| 2024-08-07 | JP Morgan | Neutral | Neutral | Maintains |
| 2024-08-07 | Citigroup | Buy | Buy | Maintains |
| 2024-10-17 | Leerink Partners | Outperform | Outperform | Maintains |
| 2025-02-10 | Piper Sandler | Overweight | Overweight | Maintains |
| 2025-02-03 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2025-03-11 | Stephens & Co. | Overweight | Overweight | Reiterate |
| 2025-03-11 | Canaccord Genuity | Hold | Hold | Maintains |
| 2024-08-13 | Piper Sandler | Overweight | Overweight | Maintains |
| 2024-12-11 | Citigroup | Buy | Neutral | Downgrade |
| 2024-11-11 | Piper Sandler | Overweight | Overweight | Maintains |
| 2025-01-13 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2025-05-09 | JP Morgan | Neutral | Neutral | Maintains |
| 2024-10-10 | RBC Capital | Outperform | Outperform | Reiterate |
| 2024-10-15 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2025-04-08 | RBC Capital | Outperform | Outperform | Maintains |
| 2025-02-10 | Barclays | Equal-Weight | Underweight | Downgrade |
| 2025-05-15 | Piper Sandler | Overweight | Overweight | Maintains |
| 2025-03-04 | Citigroup | Neutral | Neutral | Maintains |
| 2025-03-12 | RBC Capital | Outperform | Outperform | Maintains |
| 2025-04-10 | Barclays | Underweight | Underweight | Maintains |
| 2025-04-29 | Canaccord Genuity | Hold | Hold | Maintains |
| 2025-05-12 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2025-05-12 | Canaccord Genuity | Hold | Hold | Maintains |
| 2025-07-11 | Scotiabank | Sector Outperform | Sector Perform | Downgrade |
| 2025-07-28 | Baird | Neutral | Neutral | Maintains |
| 2025-05-20 | Stephens & Co. | Overweight | Overweight | Reiterate |
| 2025-07-08 | Evercore ISI Group | Outperform | Outperform | Maintains |
| 2025-08-01 | Barclays | Underweight | Underweight | Maintains |
| 2025-08-04 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2025-06-11 | Canaccord Genuity | Hold | Hold | Maintains |
